then I trust you’ve made a lot of money on the back of the SP rise.
not sure why so defensive in response.
Who knows what BMS have or haven’t looked at.
I don’t think that’s exactly what I said about suppository but I thought the NOXCOVID trial was enrolling patients with less severe disease ( who scale 3-4) right? So wouldn’t say death imminent. Look forward to seeing data from that and iconic trial.
BMS NOX to partner on pilot study, page-7
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
